StockTipsArenaBeta

BUY Gland Pharma Limited — Chandan Taparia, Motilal Oswal

BUYGland Pharma Limited
Gland Pharma share price target & all analyst calls

byChandan Taparia, Motilal OswalHorizon: BTST26 Aug 2026, 3:29 pm ISTvia CNBC Awaaz.

Entry₹2,903.2Inferred
Target₹3,000
Total upside +3.33% (call closed)
Stop loss₹2,850-1.83% risk
At expiry₹2,871.427 Aug 2026, 3:20 pm
Expired-1.10%
Follow Chandan Taparia for new calls(13% target hit, 72 closed calls)Get alertsWatch GLAND for new buy/sell callsGet alertsSee 1 active BTST pick this session

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 27 Aug 2026
3 supporting0 opposing
Supports the BUY call (3)

Gland Pharma Signs CDMO Deal Targeting USD 90-100 Million Annual Revenue

NewsGoogle News·26 Aug · yesterday

(opens in new tab)

Gland Pharma FY26 Results: Net profit surges 47% to ₹10,273 mn

NewsGoogle News·25 Aug · yesterday

(opens in new tab)

The biggest upgrades and downgrades by Jefferies during the Q1 results season

NewsCnbc-Tv18·20 Aug · 1w ago

(opens in new tab)
Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Gland Pharma

All analyst calls on Gland Pharma

More from Chandan Taparia, Motilal Oswal

Every call and its outcome